<DOC>
	<DOCNO>NCT01258686</DOCNO>
	<brief_summary>The purpose study determine effectiveness silymarin 700 mg thrice daily ass safety patient hepatitis C virus infection compare placebo .</brief_summary>
	<brief_title>Clinical Study With Silymarin Patients With Chronic Hepatitis C Infection Who Failed Conventional Antiviral Therapy</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Antiviral Agents</mesh_term>
	<mesh_term>Silymarin</mesh_term>
	<criteria>1 . Age least 18 year screen . 2 . Serum HCV RNA quantifiable level detection end previous therapy . 3 . ALT &gt; 60 IU/L ( i.e. , approximately 1.5 X upper limit normal ) obtain screening period . 4 . Previous treatment interferonbased therapy 1 ) without sustain virological response 2 ) HCV RNA detect end treatment 3 ) HCV RNA undetected treatment detect 4 ) partial response ( HCV RNA &lt; 2log10 eradicate ) 5 ) response 6 ) discontinuation due side effect 5 . Negative urine pregnancy test ( woman childbearing potential ) . Females childbearing potential must use effective contraception study . 1 . ALT ≥ 10*ULN ( Upper Limit Normal ) screen 2 . Use silymarin milk thistle preparation within 30 day prior screen . 3 . Use antioxidant vitamin E , vitamin C , glutathione , alphatocopherol , nonprescribed complementary alternative medication ( include dietary supplement , megadose vitamin , herbal preparation , special tea ) within 30 day prior screen . A multivitamin standard dose allow . 4 . Use silymarin antioxidant nonprescribed complementary alternative medication ( ) screen period patient unwilling refrain take medication completion study . 5 . Any antiviral therapy within 6 month prior screen visit . 6 . Known allergy/sensitivity milk thistle preparation . 7 . Evidence poorlycontrolled diabetes ( define HbA1c &gt; 8 % patient diabetes ) . 8 . Use warfarin , metronidazole acetaminophen ( great two gram per day ) within 30 day screen . 9 . Previous Radiology test ( Ultrasonography , Computed tomography , Magnetic Resonance Imaging ) liver biopsy demonstrate presence moderate severe steatosis evidence steatohepatitis . 10 . Positive test antiHIV HBsAg within 5 year screen . 11 . Average alcohol consumption one drink equivalent ( &gt; 12 gram ) per day two ( 2 ) drink one day 30 day prior screen . Patients meet either criterion 30 day ago must consume monthly average 12 gram less per day alcohol least six month prior screen . 12 . History chronic liver disease , include metabolic disease , document appropriate test ( ) . 13 . Women ongoing pregnancy breastfeeding , contemplate pregnancy . 14 . Serum creatinine level 2.0 mg/dL great screen CrCl ≤ 60cc/min , currently dialysis . The creatinine clearance ( CrCl ) calculate accord CockcroftGault . 15 . Evidence drug abuse within 6 month prior screen screen period . 16 . Evidence decompensated liver disease define follow : serum albumin &lt; 3.2 g/dl , total bilirubin &gt; 2.0 mg/dl , PT/INR &gt; 1.3 time normal screening , history presence ascites encephalopathy , bleed esophageal varix . 17 . History evidence severe illness condition would make patient , opinion investigator , unsuitable study ( poorly control psychiatric disease , coronary artery disease , active gastrointestinal condition might interfere drug absorption ) . 18 . History immunologically mediate disease ( e.g. , inflammatory bowel disease , idiopathic thrombocytopenic purpura , lupus erythematosus , autoimmune hepatitis , autoimmune hemolytic anemia , severe psoriasis , rheumatoid arthritis ) could affect inflammatory biomarkers . 19 . History solid organ bone marrow transplantation . 20 . History thyroid disease poorly control prescribed medication . 21 . Use oral steroid 14 day within 30 day prior screen . 22 . Participation research drug trial within 6 month enrollment . 23 . Inability unwillingness provide inform consent abide study protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>